• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者合并细菌感染时肝脏储备功能不良的影响:一项基于人群的研究。

Effects of poor hepatic reserve in cirrhotic patients with bacterial infections: A population-based study.

作者信息

Hung Tsung-Hsing, Tsai Chih-Chun, Lee Hsing-Feng

机构信息

Division of Gastroenterology, Department of Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan.

School of Medicine, Tzu Chi University, Hualien, Taiwan.

出版信息

Tzu Chi Med J. 2019 Feb 18;32(1):47-52. doi: 10.4103/tcmj.tcmj_142_18. eCollection 2020 Jan-Mar.

DOI:10.4103/tcmj.tcmj_142_18
PMID:32110520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7015002/
Abstract

OBJECTIVE

Ascites, hepatic encephalopathy, hepatorenal syndrome, spontaneous bacterial peritonitis, and esophageal variceal bleeding are major complications associated with cirrhosis. The presence of these complications indicates poor hepatic reserve. This study aimed to identify the effects of poor hepatic reserve on mortality in cirrhotic patients with bacterial infections.

PATIENTS AND METHODS

The Taiwan National Health Insurance Database was used to identify 43,042 cirrhotic patients with bacterial infections hospitalized between January 1, 2010, and December 31, 2013, after propensity score matching analysis. Of these, 21,521 cirrhotic patients had major cirrhotic-related complications and were considered to have poor hepatic reserve.

RESULTS

Mortality rates at 30 and 90 days were 24.2% and 39.5% in the poor hepatic reserve group and 12.8% and 21.7% in the good hepatic reserve group, respectively ( < 0.001 for each group). The cirrhotic patients with poor hepatic reserve (hazard ratio [HR], 2.10; 95% confidence interval [CI] = 2.03-2.18; < 0.001) had significantly increased mortality at 90 days. The mortality HRs in patients with one, two, and three or more complications compared to patients without complications were 1.92 (95% CI = 1.85-1.99, < 0.001), 2.61 (95% CI = 2.47-2.77, < 0.001), and 3.81 (95% CI = 3.18-4.57, < 0.001), respectively.

CONCLUSION

In cirrhotic patients with bacterial infections, poor hepatic reserve is associated with a poor prognosis. The presence of three or more cirrhotic-related complications increases mortality almost four folds.

摘要

目的

腹水、肝性脑病、肝肾综合征、自发性细菌性腹膜炎和食管静脉曲张破裂出血是肝硬化相关的主要并发症。这些并发症的出现表明肝脏储备功能差。本研究旨在确定肝脏储备功能差对肝硬化合并细菌感染患者死亡率的影响。

患者与方法

在进行倾向得分匹配分析后,利用台湾国民健康保险数据库确定了2010年1月1日至2013年12月31日期间住院的43042例肝硬化合并细菌感染患者。其中,21521例肝硬化患者出现了主要的肝硬化相关并发症,被认为肝脏储备功能差。

结果

肝脏储备功能差的患者30天和90天死亡率分别为24.2%和39.5%,肝脏储备功能良好的患者分别为12.8%和21.7%(每组均<0.001)。肝脏储备功能差的肝硬化患者90天死亡率显著增加(风险比[HR],2.10;95%置信区间[CI]=2.03-2.18;<0.001)。与无并发症的患者相比,有1种、2种和3种及以上并发症的患者的死亡HR分别为1.92(95%CI=1.85-1.99,<0.001)、2.61(95%CI=2.47-2.77,<0.001)和3.81(95%CI=3.18-4.57,<0.001)。

结论

在肝硬化合并细菌感染的患者中,肝脏储备功能差与预后不良相关。出现3种及以上肝硬化相关并发症会使死亡率增加近4倍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85d/7015002/ea1f92cbb79a/TCMJ-32-47-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85d/7015002/ec3dd9abd56d/TCMJ-32-47-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85d/7015002/268dce7f79b6/TCMJ-32-47-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85d/7015002/ea1f92cbb79a/TCMJ-32-47-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85d/7015002/ec3dd9abd56d/TCMJ-32-47-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85d/7015002/268dce7f79b6/TCMJ-32-47-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85d/7015002/ea1f92cbb79a/TCMJ-32-47-g003.jpg

相似文献

1
Effects of poor hepatic reserve in cirrhotic patients with bacterial infections: A population-based study.肝硬化患者合并细菌感染时肝脏储备功能不良的影响:一项基于人群的研究。
Tzu Chi Med J. 2019 Feb 18;32(1):47-52. doi: 10.4103/tcmj.tcmj_142_18. eCollection 2020 Jan-Mar.
2
The role of hepatic reserve in the mortality of cirrhotic patients with small hepatocellular carcinoma receiving radiofrequency ablation.肝储备功能在接受射频消融治疗的小肝细胞癌肝硬化患者死亡率中的作用。
Medicine (Baltimore). 2022 Oct 7;101(40):e30918. doi: 10.1097/MD.0000000000030918.
3
The effect of bacterial infections in cirrhotic patients with esophageal variceal bleeding.肝硬化合并食管静脉曲张破裂出血患者的细菌感染效应。
Ann Hepatol. 2014 May-Jun;13(3):364-9.
4
High Mortality of Cirrhotic Patients With End-Stage Renal Disease.终末期肾病肝硬化患者的高死亡率
Medicine (Baltimore). 2016 Mar;95(10):e3057. doi: 10.1097/MD.0000000000003057.
5
Glucagon-Like Peptide-1 Receptor Agonists and Hepatic Decompensation Events in Patients With Cirrhosis and Diabetes.胰高血糖素样肽-1 受体激动剂与肝硬化合并糖尿病患者肝性失代偿事件。
Clin Gastroenterol Hepatol. 2022 Jun;20(6):1382-1393.e19. doi: 10.1016/j.cgh.2021.07.010. Epub 2021 Jul 10.
6
No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment.在患有食管静脉曲张破裂出血和肾功能损害的肝硬化患者中,特利加压素和生长抑素治疗的死亡率无差异。
Eur J Gastroenterol Hepatol. 2016 Nov;28(11):1275-9. doi: 10.1097/MEG.0000000000000703.
7
The effect of infections on the mortality of cirrhotic patients with hepatic encephalopathy.感染对肝性脑病肝硬化患者死亡率的影响。
Epidemiol Infect. 2013 Dec;141(12):2671-8. doi: 10.1017/S0950268813000186. Epub 2013 Feb 22.
8
The Effect of the First Spontaneous Bacterial Peritonitis Event on the Mortality of Cirrhotic Patients with Ascites: A Nationwide Population-Based Study in Taiwan.首次自发性细菌性腹膜炎事件对肝硬化腹水患者死亡率的影响:台湾一项基于全国人口的研究
Gut Liver. 2016 Sep 15;10(5):803-7. doi: 10.5009/gnl13468.
9
Impact of rifaximin use in infections and mortality in patients with decompensated cirrhosis and hepatic encephalopathy.利福昔明用于失代偿期肝硬化和肝性脑病患者感染及死亡率的影响
Therap Adv Gastroenterol. 2024 May 27;17:17562848241254267. doi: 10.1177/17562848241254267. eCollection 2024.
10
Prevalence of cirrhotic cardiomyopathy and its relationship with serum pro-brain natriuretic peptide, hepatorenal syndrome, spontaneous bacterial peritonitis, and mortality.肝硬化心肌病的患病率及其与血清脑利钠肽前体、肝肾综合征、自发性细菌性腹膜炎和死亡率的关系。
Indian J Gastroenterol. 2020 Oct;39(5):481-486. doi: 10.1007/s12664-020-01083-2. Epub 2020 Nov 13.

本文引用的文献

1
Selective cyclooxygenase inhibition by SC-560 improves hepatopulmonary syndrome in cirrhotic rats.SC-560选择性抑制环氧化酶可改善肝硬化大鼠的肝肺综合征。
PLoS One. 2017 Jun 20;12(6):e0179809. doi: 10.1371/journal.pone.0179809. eCollection 2017.
2
Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study.他汀类药物降低乙型肝炎病毒和丙型肝炎病毒相关肝硬化失代偿的风险:一项基于人群的研究。
Hepatology. 2017 Sep;66(3):896-907. doi: 10.1002/hep.29172. Epub 2017 May 8.
3
Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.
他汀类药物降低慢性乙型肝炎患者肝硬化及其失代偿风险:一项全国性队列研究。
Am J Gastroenterol. 2016 Jul;111(7):976-85. doi: 10.1038/ajg.2016.179. Epub 2016 May 10.
4
The Beneficial Effect of Beta-Blockers in Patients With Cirrhosis, Portal Hypertension and Ascites.β受体阻滞剂对肝硬化、门静脉高压和腹水患者的有益作用。
Am J Med Sci. 2016 Feb;351(2):169-76. doi: 10.1016/j.amjms.2015.11.018.
5
Can proton pump inhibitors reduce rebleeding following Histoacryl sclerotherapy for gastric variceal hemorrhage?质子泵抑制剂能否降低组织黏合剂硬化治疗胃静脉曲张出血后的再出血率?
Korean J Intern Med. 2015 Sep;30(5):593-601. doi: 10.3904/kjim.2015.30.5.593. Epub 2015 Aug 27.
6
Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance.肝硬化相关免疫功能障碍:特征和临床相关性。
J Hepatol. 2014 Dec;61(6):1385-96. doi: 10.1016/j.jhep.2014.08.010. Epub 2014 Aug 15.
7
Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation.阿司匹林可能减缓肝纤维化进展:来自肝移植后复发性丙型肝炎多中心回顾性研究的证据。
Clin Res Hepatol Gastroenterol. 2014 Oct;38(5):570-6. doi: 10.1016/j.clinre.2014.07.004. Epub 2014 Aug 15.
8
Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes.在诊断为肝硬化后继续使用二甲双胍可显著改善糖尿病患者的生存。
Hepatology. 2014 Dec;60(6):2008-16. doi: 10.1002/hep.27199. Epub 2014 Jul 31.
9
Immune dysfunction in cirrhosis.肝硬化中的免疫功能障碍。
World J Gastroenterol. 2014 Mar 14;20(10):2564-77. doi: 10.3748/wjg.v20.i10.2564.
10
High mortality of pneumonia in cirrhotic patients with ascites.肝硬化伴腹水患者肺炎死亡率高。
BMC Gastroenterol. 2013 Feb 7;13:25. doi: 10.1186/1471-230X-13-25.